Coloplast A/S CLPBF
OTC PK
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 182.62M | 227.53M | -152.07M | 217.74M | 137.07M |
| Total Depreciation and Amortization | 32.03M | 56.49M | 54.66M | 53.77M | 28.51M |
| Total Amortization of Deferred Charges | 25.25M | -- | -- | -- | 40.10M |
| Total Other Non-Cash Items | 52.20M | -14.47M | 406.09M | 48.16M | 119.05M |
| Change in Net Operating Assets | 107.78M | -3.42M | -79.09M | 28.37M | 30.08M |
| Cash from Operations | 399.88M | 266.12M | 229.59M | 348.05M | 354.80M |
| Capital Expenditure | -53.89M | -40.46M | -63.27M | -57.98M | -57.65M |
| Sale of Property, Plant, and Equipment | 154.00K | 311.30K | 1.10M | 311.70K | 156.60K |
| Cash Acquisitions | 0.00 | 311.30K | -22.08M | -- | -- |
| Divestitures | -- | -- | -- | -- | 0.00 |
| Other Investing Activities | -9.55M | -5.60M | -11.59M | -6.55M | -3.60M |
| Cash from Investing | -63.28M | -45.44M | -95.85M | -64.22M | -61.09M |
| Total Debt Issued | -522.00M | -834.00M | -507.00M | 2.48B | 1.18B |
| Total Debt Repaid | -1.97B | 280.00M | -427.00M | -69.00M | -2.83B |
| Issuance of Common Stock | -- | -- | -- | -- | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -175.24M | 0.00 | -632.35M | 0.00 |
| Other Financing Activities | -4.06B | -- | -- | -- | -3.83B |
| Cash from Financing | -383.86M | -261.45M | -146.27M | -255.93M | -257.53M |
| Foreign Exchange rate Adjustments | 154.00K | 1.87M | 2.98M | -155.90K | -1.57M |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | 469.80K | -- | -- |
| Net Change in Cash | -47.12M | -38.91M | -9.08M | 27.74M | 34.62M |